Company / Return on Equity (ROE)
IRADIMED CORP Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
23.8%
FY2025
5-year range
12.9% / 24.1%
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
#12 of 148
Health Care
What the data says
Among 148 Health Care companies, IRADIMED CORP is in the top 8% for return on equity (roe). Return on Equity (ROE) has fluctuated over the past 10 years, ranging from 2.2% in FY2020 to 24.1% in FY2023.
Based on SEC 10-K filings.
23.8% in FY2025 with a 5-year CAGR of +21.5%. Top quartile in the Health Care sector.
Remained stable around 23.8% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +10.8pp
- 5-Year Change
- +21.5pp
- 10-Year Change
- -
Sector benchmark
Top 8% in Health CareTop 8% of 148This company 23.8% Sector average -3.2%
▼
+852.3% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 7.3% year-over-year.
- Currently 26.9pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2023.
- Lowest return on equity (roe) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 23.8% | +7.3% |
| FY2024 | 22.1% | -8.0% |
| FY2023 | 24.1% | +86.3% |
| FY2022 | 12.9% | -17.7% |
| FY2021 | 15.7% | +603.6% |
| FY2020 | 2.2% | -87.1% |
| FY2019 | 17.3% | -23.3% |
| FY2018 | 22.6% | -4.1% |
| FY2017 | 23.6% | +140.4% |
| FY2016 | 9.8% | -74.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026